Natco Pharma to invest $14 mn in US-based biotechnology firm eGenesis Inc
In 2024, Natco Pharma had invested $8 million in eGenesis, Inc through preferred stock
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.